Telementoring Intervention (ECHO) for the Transformation of Professional Engagement, Practice Efficiency, and Community Building Through Team Meetings in Diagnostic Imaging Clinicians
NCT ID: NCT04196972
Last Updated: 2025-10-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
36 participants
INTERVENTIONAL
2020-08-16
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ensuring Communication in Hospice by Oncology Study (ECHO)
NCT02069769
An Educational Intervention on Provider Knowledge for the Support of Cancer Survivors
NCT06062901
Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology
NCT05496972
Psycho-Educational Cognition Intervention in Patients With Blood and Lymph Cancer
NCT03804164
A Multifaceted Telemedicine-Based Intervention to Improve Outcomes of Cancer Patients Admitted to the ICU
NCT05423795
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To determine the feasibility of the proposed anti-burnout intervention for faculty at MD Anderson, defined as at least 35/50 of participants each attending at least 9 out of 13 sessions.
SECONDARY OBJECTIVES:
I. To explore any changes in burnout, measured by the Maslach Burnout Inventory (MBI) and Mini-Z surveys.
II. To explore any changes in the self-reported health status of participants, as measured by the RAND Short-Form 36 (SF36) survey.
III. To understand participants' perception of the benefits and usefulness of the intervention, measured by the customized Globalized Perception/Impression of Benefits Survey.
IV. To define methods for improving the intervention, based on participants' feedback following each session.
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM A: Participants attend ECHO telementoring sessions over 1 hour weekly for 13 weeks.
ARM B: Participants are placed on a wait-list for 13 weeks and then attend ECHO telementoring sessions over 1 hour weekly for 13 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm A (ECHO telementoring)
Participants attend ECHO telementoring sessions over 1 hour weekly for 13 weeks.
Communication Intervention
Receive ECHO telementoring intervention
Questionnaire Administration
Ancillary studies
Arm B (wait-list, ECHO telementoring)
Participants are placed on a wait-list for 13 weeks and then attend ECHO telementoring sessions over 1 hour weekly for 13 weeks.
Communication Intervention
Receive ECHO telementoring intervention
Questionnaire Administration
Ancillary studies
Waiting List
Placed on wait-list
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Communication Intervention
Receive ECHO telementoring intervention
Questionnaire Administration
Ancillary studies
Waiting List
Placed on wait-list
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Faculty that have previously participated in any previous live ECHO clinic or ECHO activity
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eduardo Bruera
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
M D Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2019-07565
Identifier Type: REGISTRY
Identifier Source: secondary_id
2019-0639
Identifier Type: OTHER
Identifier Source: secondary_id
2019-0639
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.